TD Cowen Cuts HCA Healthcare (NYSE:HCA) Price Target to $360.00

HCA Healthcare (NYSE:HCA) had its price objective reduced by equities research analysts at TD Cowen from $371.00 to $360.00 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. TD Cowen’s target price suggests a potential upside of 16.05% from the company’s current price.

A number of other equities research analysts also recently weighed in on the company. Truist Financial raised their price target on HCA Healthcare from $320.00 to $345.00 and gave the stock a “buy” rating in a research note on Wednesday, January 31st. Barclays raised their target price on HCA Healthcare from $356.00 to $367.00 and gave the company an “overweight” rating in a report on Monday. Deutsche Bank Aktiengesellschaft increased their price target on HCA Healthcare from $330.00 to $359.00 and gave the company a “buy” rating in a report on Friday, April 12th. Cantor Fitzgerald restated an “overweight” rating and set a $335.00 price target on shares of HCA Healthcare in a report on Wednesday, April 10th. Finally, Sanford C. Bernstein lowered HCA Healthcare from an “outperform” rating to a “market perform” rating and upped their price target for the stock from $277.00 to $301.00 in a report on Thursday, January 4th. Four analysts have rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $316.59.

HCA Healthcare Trading Down 0.4 %

Shares of HCA Healthcare stock traded down $1.22 on Tuesday, reaching $310.20. 205,904 shares of the company were exchanged, compared to its average volume of 1,097,533. HCA Healthcare has a fifty-two week low of $215.96 and a fifty-two week high of $335.83. The stock has a fifty day moving average price of $323.67 and a 200-day moving average price of $295.56. The firm has a market capitalization of $82.04 billion, a price-to-earnings ratio of 15.47, a price-to-earnings-growth ratio of 1.48 and a beta of 1.65. The company has a current ratio of 1.16, a quick ratio of 1.02 and a debt-to-equity ratio of 29.26.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, April 26th. The company reported $5.36 earnings per share for the quarter, beating analysts’ consensus estimates of $5.01 by $0.35. The business had revenue of $17.34 billion for the quarter, compared to the consensus estimate of $16.81 billion. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. HCA Healthcare’s revenue for the quarter was up 11.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $4.93 earnings per share. On average, analysts expect that HCA Healthcare will post 20.58 EPS for the current year.

HCA Healthcare declared that its board has approved a share repurchase program on Tuesday, January 30th that allows the company to repurchase $6.00 billion in outstanding shares. This repurchase authorization allows the company to buy up to 7.4% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company’s board believes its shares are undervalued.

Insider Activity

In other HCA Healthcare news, SVP Kathryn A. Torres sold 3,861 shares of the firm’s stock in a transaction dated Wednesday, January 31st. The shares were sold at an average price of $307.00, for a total value of $1,185,327.00. Following the completion of the sale, the senior vice president now owns 15,899 shares in the company, valued at approximately $4,880,993. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, SVP Kathryn A. Torres sold 3,861 shares of the business’s stock in a transaction that occurred on Wednesday, January 31st. The shares were sold at an average price of $307.00, for a total value of $1,185,327.00. Following the completion of the transaction, the senior vice president now owns 15,899 shares in the company, valued at approximately $4,880,993. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Kathleen M. Whalen sold 4,262 shares of HCA Healthcare stock in a transaction on Friday, February 9th. The shares were sold at an average price of $306.21, for a total value of $1,305,067.02. Following the completion of the sale, the senior vice president now directly owns 10,250 shares of the company’s stock, valued at $3,138,652.50. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 14,840 shares of company stock worth $4,588,869. 1.70% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On HCA Healthcare

Several large investors have recently bought and sold shares of HCA. Parkside Financial Bank & Trust lifted its stake in shares of HCA Healthcare by 8.2% in the 4th quarter. Parkside Financial Bank & Trust now owns 461 shares of the company’s stock valued at $125,000 after purchasing an additional 35 shares during the period. FinTrust Capital Advisors LLC boosted its holdings in HCA Healthcare by 26.7% during the fourth quarter. FinTrust Capital Advisors LLC now owns 166 shares of the company’s stock worth $45,000 after buying an additional 35 shares during the last quarter. Ballentine Partners LLC increased its stake in shares of HCA Healthcare by 1.0% in the 1st quarter. Ballentine Partners LLC now owns 3,879 shares of the company’s stock valued at $1,294,000 after acquiring an additional 38 shares during the last quarter. Wedmont Private Capital grew its holdings in HCA Healthcare by 1.6% during the fourth quarter. Wedmont Private Capital now owns 2,527 shares of the company’s stock valued at $711,000 after purchasing an additional 39 shares during the period. Finally, Valley Wealth Managers Inc. boosted its position in shares of HCA Healthcare by 4.1% during the fourth quarter. Valley Wealth Managers Inc. now owns 981 shares of the company’s stock worth $266,000 after purchasing an additional 39 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.